Reimbursement and Market Access for Medical Devices in Taiwan
Obtaining a high device reimbursement price from Taiwan’s Bureau of National Health Insurance.
To learn more about Taiwan medical device reimbursement, please contact us.
The universal healthcare system of Taiwan, known as the National Healthcare Insurance Program (NHI), has existed since 1995. The NHI regulator, the Bureau of National Health Insurance (BNHI), usually runs deficits, making them especially interested in cost-cutting measures with respect to medical products.
The BNHI has two reimbursement approval systems in place for medical devices: a fee for service schedule and a case payment system. When assigning a reimbursement price for a new medical device, the BNHI will compare the new product with similar products on the Taiwan market. Generally, the BNHI will request a new applicant to provide a list of published reimbursement prices from other countries, and will typically grant a reimbursement price that is in the low to middle range of those prices.
The self-paid market for higher quality products is becoming more popular in Taiwan’s hospitals. As the BNHI continues to face increasing financial pressure, achieving medical device reimbursement in Taiwan can be very challenging.
To learn more about Taiwan medical device reimbursement, please contact us.
Related Resources
Visit our Resource Center to view free webcasts and charts or read publications, news, and research reports on the Asia medical markets.
Related News Briefs
Visit our Resource Center to view free webcasts and charts or read publications, news, and research reports on the Asia medical markets.